BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 19501186)

  • 1. In vitro micronucleus test in HepG2 transformants expressing a series of human cytochrome P450 isoforms with chemicals requiring metabolic activation.
    Hashizume T; Yoshitomi S; Asahi S; Matsumura S; Chatani F; Oda H
    Mutat Res; 2009; 677(1-2):1-7. PubMed ID: 19501186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advantages of human hepatocyte-derived transformants expressing a series of human cytochrome p450 isoforms for genotoxicity examination.
    Hashizume T; Yoshitomi S; Asahi S; Uematsu R; Matsumura S; Chatani F; Oda H
    Toxicol Sci; 2010 Aug; 116(2):488-97. PubMed ID: 20507880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome P450 enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells.
    Westerink WM; Schoonen WG
    Toxicol In Vitro; 2007 Dec; 21(8):1581-91. PubMed ID: 17637504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of the transformants expressing human cytochrome P450 subtypes in HepG2, and their applications on drug metabolism and toxicology.
    Yoshitomi S; Ikemoto K; Takahashi J; Miki H; Namba M; Asahi S
    Toxicol In Vitro; 2001 Jun; 15(3):245-56. PubMed ID: 11377097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitrogen-substitution effects on the mutagenicity and cytochrome P450 isoform-selectivity of chrysene analogs.
    Yamada K; Hakura A; Kato TA; Mizutani T; Saeki K
    Mutat Res; 2005 Sep; 586(1):87-95. PubMed ID: 16087391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochrome P450 expression and activities in human tongue cells and their modulation by green tea extract.
    Yang SP; Raner GM
    Toxicol Appl Pharmacol; 2005 Jan; 202(2):140-50. PubMed ID: 15629189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marine toxin okadaic acid induces aneuploidy in CHO-K1 cells in presence of rat liver postmitochondrial fraction, revealed by cytokinesis-block micronucleus assay coupled to FISH.
    Le Hégarat L; Fessard V; Poul JM; Dragacci S; Sanders P
    Environ Toxicol; 2004 Apr; 19(2):123-8. PubMed ID: 15037998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategy for genotoxicity testing--metabolic considerations.
    Ku WW; Bigger A; Brambilla G; Glatt H; Gocke E; Guzzie PJ; Hakura A; Honma M; Martus HJ; Obach RS; Roberts S;
    Mutat Res; 2007 Feb; 627(1):59-77. PubMed ID: 17141553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of multiple cytochrome P450 and UDP-glucuronosyltransferase enzymes in the in vitro metabolism of muraglitazar.
    Zhang D; Wang L; Chandrasena G; Ma L; Zhu M; Zhang H; Davis CD; Humphreys WG
    Drug Metab Dispos; 2007 Jan; 35(1):139-49. PubMed ID: 17062778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotoxicity of tamoxifen, tamoxifen epoxide and toremifene in human lymphoblastoid cells containing human cytochrome P450s.
    Styles JA; Davies A; Lim CK; De Matteis F; Stanley LA; White IN; Yuan ZX; Smith LL
    Carcinogenesis; 1994 Jan; 15(1):5-9. PubMed ID: 8293548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative aflatoxin B(1) activation and cytotoxicity in human bronchial cells expressing cytochromes P450 1A2 and 3A4.
    Van Vleet TR; Macé K; Coulombe RA
    Cancer Res; 2002 Jan; 62(1):105-12. PubMed ID: 11782366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro metabolism study of buprenorphine: evidence for new metabolic pathways.
    Picard N; Cresteil T; Djebli N; Marquet P
    Drug Metab Dispos; 2005 May; 33(5):689-95. PubMed ID: 15743975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Application of TK6-derived Cells Expressing Human Cytochrome P450s for Genotoxicity Testing.
    Li X; Chen S; Guo X; Wu Q; Seo JE; Guo L; Manjanatha MG; Zhou T; Witt KL; Mei N
    Toxicol Sci; 2020 Jun; 175(2):251-265. PubMed ID: 32159784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotoxic effects of dietary and lifestyle related carcinogens in human derived hepatoma (HepG2, Hep3B) cells.
    Majer BJ; Mersch-Sundermann V; Darroudi F; Laky B; de Wit K; Knasmüller S
    Mutat Res; 2004 Jul; 551(1-2):153-66. PubMed ID: 15225590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of PCB153 on BaP-induced genotoxicity in HepG2 cells via modulation of metabolic enzymes.
    Wei W; Zhang C; Liu AL; Xie SH; Chen XM; Lu WQ
    Mutat Res; 2009 Apr; 675(1-2):71-6. PubMed ID: 19386251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotoxic activation of the environmental pollutant 3,6-dinitrobenzo[e]pyrene in Salmonella typhimurium umu strains expressing human cytochrome P450 and N-acetyltransferase.
    Oda Y; Hirayama T; Watanabe T
    Toxicol Lett; 2009 Aug; 188(3):258-62. PubMed ID: 19393727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of the use of primary Chinese hamster liver cultures and genetically engineered immortal V79 Chinese hamster cell lines expressing rat liver CYP1A1, 1A2 and 2B1 cDNAs in micronucleus assays.
    Ellard S; Parry JM
    Toxicology; 1993 Oct; 82(1-3):131-49. PubMed ID: 8236272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of colchicine and its derivatives on the expression of selected isoforms of cytochrome P450 in primary cultures of human hepatocytes.
    Dvorák Z; Ulrichová J; Modrianský M; Maurel P
    Acta Univ Palacki Olomuc Fac Med; 2000; 143():47-50. PubMed ID: 11144118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of ten strains of genetically engineered Salmonella typhimurium TA1538 each co-expressing a form of human cytochrome P450 with NADPH-cytochrome P450 reductase sensitive to various promutagens.
    Yamazaki Y; Fujita K; Nakayama K; Suzuki A; Nakamura K; Yamazaki H; Kamataki T
    Mutat Res; 2004 Aug; 562(1-2):151-62. PubMed ID: 15279838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of cytotoxic, genotoxic and CYP450 enzymatic competition effects of Tanzanian plant extracts traditionally used for treatment of fungal infections.
    van den Bout-van den Beukel CJ; Hamza OJ; Moshi MJ; Matee MI; Mikx F; Burger DM; Koopmans PP; Verweij PE; Schoonen WG; van der Ven AJ
    Basic Clin Pharmacol Toxicol; 2008 Jun; 102(6):515-26. PubMed ID: 18331392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.